Add BrightSurf on Google Email

Research uncovers possible monoclonal antibody treatment for Lassa fever

Researchers at the University of Texas Medical Branch have identified a possible treatment for Lassa fever, a highly infectious and often fatal disease. A new monoclonal antibody cocktail, Arevirumab-3, was shown to successfully treat cynomolgus monkeys infected with the virus in advanced stages.

SourceUniversity of Texas Medical Branch at Galveston·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 24, 2023

Dogs can detect COVID-19 infections faster and more accurately than conventional technology, demonstrating readiness for mainstream medical applications

A growing number of studies highlights the power of dogs in detecting COVID-19 and its variants, even when obscured by other viruses. Trained scent dogs are as effective and often more effective than antigen tests and RT-PCR tests, detecting the virus faster and without environmental impact.

SourceUniversity of California - Santa Barbara·JournalJournal of Osteopathic Medicine·DateAug 14, 2023

How to increase acceptance of an RSV vaccine? Explain the FDA’s vaccine approval process

A new study by the Annenberg Public Policy Center found that people are more likely to recommend an RSV vaccine if they understand the rigorous process of the FDA's vaccine approval process. The study showed that 57% of those exposed to a flowchart were very or somewhat likely to recommend the vaccine, compared to 40% in a control group.

Why we lose fat and muscle during infection

Researchers found that CD4+ T cells initiate fat wasting, while CD8+ T cells induce muscle wasting, which surprisingly helps the mice fight infection and survive. The study sheds light on the complex relationship between immune cells and wasting responses.

SourceSalk Institute·JournalCell Reports·DateJul 24, 2023

Scientific breakthrough harnesses mRNA technology to develop powerful malaria vaccine

A breakthrough mRNA vaccine has been developed to target and stimulate protective immune cell responses against malaria. The vaccine combines an RNA-based approach with a liver-specific adjuvant, generating resident memory cells that halt malaria infection in the liver, providing a broader and more protective immune response.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalNature Immunology·TypeExperimental study·DateJul 20, 2023

Nanomedicine for treating inflammatory bowel disease

Researchers developed nanoparticles that mimic the glycocalyx pattern to treat inflammatory bowel disease. The treatment reduced symptoms and inflammation in mice with IBD, with specific versions showing significant improvement.

SourceWiley·JournalAngewandte Chemie International Edition·TypeExperimental study·DateJul 17, 2023

Fibromyalgia linked to heightened risk of death

A systematic review suggests fibromyalgia is associated with a 27% heightened risk of death from all causes, with elevated risks for cancer, accidents, and infections. Regular monitoring of patients' physical and mental health is crucial to minimize these risks.

SourceBMJ Group·JournalRMD Open·TypeSystematic review·DateJul 10, 2023

Vaginal suppository containing lactobacilli can prevent recurrent cystitis in women

A study published in Frontiers in Microbiology found that administering vaginal suppositories with Lactobacillus crispatus can restore a healthy balance of vaginal microbiota and prevent recurrent cystitis. The researchers discovered that postmenopausal women with RC had significantly different bacterial communities compared to those w...

SourceOkayama University·JournalFrontiers in Microbiology·TypeObservational study·DateJul 3, 2023

Arsenic levels decline for most highly exposed U.S. communities served by public water systems following final arsenic ruling

A new study by Columbia University Mailman School of Public Health found that the Final Arsenic Rule successfully reduced water arsenic exposure for many US communities, particularly those with high initial exposure levels and marginalized populations. The rule, implemented in 2006, reduced the maximum contaminant level to 10 μg/L.

Echovirus 11 in newly born twins: case in Italy shows close genetic relation to strains found in France among neonates

A case of echovirus 11-induced hepatitis in Italian male twins has been reported, showing a close genetic relation to strains found in France among neonates. The study highlights the importance of rapid recognition and timely treatment to ensure survival, and suggests potential host genetic predisposition in male and twin categories.

The tiger mosquito can transmit the chikungunya virus in temperate conditions

Scientists have found that tiger mosquitoes can transmit the chikungunya virus as effectively at 20°C as at 28°C, raising concerns about its spread in temperate regions. The study reveals different gene expression profiles and microbiome changes in infected mosquitoes, which could lead to increased transmission of the pathogen.

SourceInstitut Pasteur·JournalJournal of Travel Medicine·TypeExperimental study·DateJun 14, 2023

Making immunotherapy safer

Researchers developed CrossDome, a tool that uses genetic and biochemical information to predict T-cell immunotherapy's impact on healthy cells. The tool identified high-risk candidates in cases where treatments mistakenly attacked heart cells.

SourceUniversity of Houston·JournalFrontiers in Immunology·DateJun 14, 2023

The best drug combos to prevent COVID recurrence

A machine-learning study has found that individual characteristics, including age and weight, determine which drug combinations most effectively reduce COVID-19 recurrence rates. The study used real-world data from a hospital in China and identified unique treatment combinations for different demographic groups.

SourceUniversity of California - Riverside·JournalFrontiers in Artificial Intelligence·TypeData/statistical analysis·DateJun 13, 2023

Study investigates how the severity of effects of the SARS-CoV-2 virus in England was affected by the mass vaccination campaign and emergence of Alpha, Delta and Omicron variants between May 2020 and March 2022

Researchers analyzed hospitalization and fatality rates of SARS-CoV-2 infection in England between May 2020 and March 2022. The study found that the mass vaccination campaign significantly reduced severe effects of the virus, with notable improvements after the emergence of Alpha, Delta, and Omicron variants.

SourcePLOS·JournalPLOS Biology·DateMay 25, 2023

Inhaled ethanol may treat respiratory infections and stop pandemics

A new study found that inhaling low concentrations of ethanol vapor can inactivate the influenza A virus in mice without harmful side effects. The researchers believe this method could also treat similar viruses like Covid-19 and potentially stop pandemics. However, further evaluation is needed to ensure its efficacy and safety on humans.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalThe Journal of Infectious Diseases·TypeExperimental study·DateApr 26, 2023

Narrative risk messaging and vaccine hesitancy

Focusing public health messages on protecting oneself versus others has a significant impact on vaccination rates. A study found that messages emphasizing protection of one's community led to higher odds of COVID-19 vaccination than those focused on personal protection.

SourcePNAS Nexus·JournalPNAS Nexus·DateApr 18, 2023

Pediatric TB may affect lung functioning, growth later in life

A new study reveals that young children diagnosed with pulmonary tuberculosis are at an increased risk of subsequent wheezing, poor lung function, and reduced height and weight. The study found that children who developed PTB before six months old had more than double the risk of wheezing after 6 months.

SourceBoston University School of Public Health·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeObservational study·DateApr 18, 2023

First Nations populations at greater risk of severe flu, research finds

A new study by the Peter Doherty Institute found that First Nations populations are significantly more likely to be hospitalized and die from influenza compared to non-Indigenous populations. Influenza-associated hospitalization and mortality rates were consistently higher in First Nations communities globally.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalPLOS Global Public Health·TypeMeta-analysis·DateApr 13, 2023